Percutaneous portal vein access and transhepatic tract hemostasis

Seminars in Interventional Radiology

Volumn 29, Issue 2, 2012, Pages 71-80

  Saad, Wael E A ^a   Madoff, David C ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

coils; Gelfoam; glue (N butyl cyanoacrylate); hemostasis; Liver; percutaneous; portal vein

Indexed keywords

EID: 84862237976     PISSN: 07399529     EISSN: 10988963     Source Type: Journal    
DOI: 10.1055/s-0032-1312567     Document Type: Review

References (26)

1. Schneider N, Scanga A, Stokes L, Perri R. Portal vein stenosis: a rare yet clinically important cause of delayed-onset ascites after adult deceased donor liver transplantation: two case reports. Transplant Proc: 2011; 43 10 3829 3834
2. Saad WEA. Liver transplant-related vascular disease. In: Dake M, Geshwind J-F. eds. Abrams' Angiography: Interventional Radiology. 3rd ed. Philadelphia, PA Lippincott Williams & Wilkins. In press
3. Saad WE, Waldman DL. Endovascular repair of vascular lesions in solid organ transplantation. In: Oriel K, Katzen BT, Rosenfield K. eds. Complications in Endovascular Therapy. New York, NY Taylor & Francis Informa: 2006; 223 252
4. González-Tutor A, Abascal F, Cerezai L, Bustamante M. Transjugular approach to treat portal vein stenosis after liver transplantationa case report. Angiology: 2000; 51 6 511 514 (Pubitemid 30415817)
5. Cheng YF, Ou HY, Tsang LL., et al. Interventional percutaneous trans-splenic approach in the management of portal venous occlusion after living donor liver transplantation. Liver Transpl: 2009; 15 10 1378 1380
6. McDaniel HM, Johnson M, Pescovitz MD., et al. Intraoperative placement of a Wallstent for portal vein stenosis and thrombosis after liver transplantation. Transplantation: 1997; 63 4 607 608 (Pubitemid 27102633)
7. Woo DH, Laberge JM, Gordon RL, Wilson MW, Kerlan RK Jr. Management of portal venous complications after liver transplantation. Tech Vasc Interv Radiol: 2007; 10 3 233 239 (Pubitemid 350251239)
8. Ueda M, Egawa H, Ogawa K., et al. Portal vein complications in the long-term course after pediatric living donor liver transplantation. Transplant Proc: 2005; 37 2 1138 1140 (Pubitemid 40590815)
9. Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. Journal of vascular and interventional radiology. J Vasc Interv Radiol: 2005; 16 779 790 (Pubitemid 40847898)
10. Kodama Y, Shimizu T, Endo H, Miyamoto N, Miyasaka K. Complications of percutaneous transhepatic portal vein embolization. J Vasc Interv Radiol: 2002; 13 1233 1237 (Pubitemid 35440315)
11. Denys A, Bize P, Demartines N, Deschamps F, De Baere T.; Cardiovascular and Interventional Radiological Society of Europe Quality improvement for portal vein embolization. Cardiovasc Intervent Radiol: 2010; 33 3 452 456
12. Avritscher R, de Baere T, Murthy R, Deschamps F, Madoff DC. Percutaneous transhepatic portal vein embolization: rationale, technique, and outcomes. Semin Intervent Radiol: 2008; 25 2 132 145
13. Villiger P, Ryan EA, Owen R., et al. Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant: 2005; 5 12 2992 2998 (Pubitemid 43923962)
14. Bertuzzi F, Grohavaz F, Maffi P., et al. Successful transplantation of human islets in recipients bearing a kidney graft. Diabetologia: 2002; 45 77 84 (Pubitemid 34118545)
15. Hirshberg B, Rother KI, Digon BJ III., et al. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience. Diabetes Care: 2003; 26 12 3288 3295 (Pubitemid 37466889)
16. Ryan EA, Paty BW, Senior PA, Shapiro AM. Risks and side effects of islet transplantation. Curr Diab Rep: 2004; 4 4 304 309 (Pubitemid 39173556)
17. Weimar B, Rauber K, Brendel MD, Bretzel RG, Rau WS. Percutaneous transhepatic catheterization of the portal vein: a combined CT- and fluoroscopy-guided technique. Cardiovasc Intervent Radiol: 1999; 22 4 342 344 (Pubitemid 29379883)
18. Hering BJ, Kandaswamy R, Ansite JD., et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA: 2005; 293 7 830 835 (Pubitemid 40250366)
19. Froud T, Yrizarry JM, Alejandro R, Ricordi C. Use of D-STAT to prevent bleeding following percutaneous transhepatic intraportal islet transplantation. Cell Transplant: 2004; 13 1 55 59 (Pubitemid 38252713)
20. Bucher P, Mathe Z, Bosco D., et al. Morbidity associated with intraportal islet transplantation. Transplant Proc: 2004; 36 4 1119 1120 (Pubitemid 38766295)
21. Barshes NR, Lee T, Goodpasture S., et al. Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review. Transplant Proc: 2004; 36 4 1127 1129 (Pubitemid 38766299)
22. Venturini M, Angeli E, Maffi P., et al. Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US. Radiology: 2005; 234 2 617 624 (Pubitemid 40139939)
23. Saad WEA. Hepatic techniques for accessing the biliary tract. Tech Vasc Interv Radiol: 2008; 11 21 42
24. Iezzi R, Pedicelli A, Pirro F., et al. Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note. Cardiovasc Intervent Radiol: 2011; 34 435 439
25. Cekirge S, Akhan O, Ozmen M, Saatci I, Besim A. Malignant biliary obstruction complicated by ascites: closure of the transhepatic tract with cyanoacrylate glue after placement of endoprosthesis. Cardiovasc Intervent Radiol: 1997; 20 228 231 (Pubitemid 27247103)
26. Brothers MF, Kaufmann JC, Fox AJ, Deveikis JP. n-Butyl 2-cyanoacrylatesubstitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. AJNR Am J Neuroradiol: 1989; 10 4 777 786 (Pubitemid 19175838)